MMIT

MMIT, a Norstella company, is a go-to-market partner for pharmaceutical and biotechnology companies, payers, and providers. Founded in 1994, the company initially operated as Medi-Media, focusing on supporting pharmaceutical clients with commercialization. It has since evolved to concentrate on solving the complexities of drug coverage and patient access to lifesaving therapies. Michael Gallup has been the CEO of MMIT since 2020 and is also the CEO of its parent company, Norstella.

The company's business model is centered on providing data, analytics, and insights that bring transparency to pharmacy and medical benefit information. It serves over 1,300 biopharma and payer clients, helping them understand market access trends and make strategic decisions. Revenue is generated through its platform, insights, and consulting services which guide therapies from the development pipeline to patients. The company's offerings include a workflow tool used in over 20,000 locations that helps physicians with test recommendations and captures proprietary lab data, which is a byproduct of this service.

MMIT has grown significantly through a series of strategic acquisitions. Its divisions include AIS Health, a healthcare publications company; Zitter Health Insights, which provides market access solutions for specialty drugs; and RJ Health, a leader in pricing and coding for infusion drugs. In 2021, MMIT united with The Dedham Group, an oncology and specialty therapeutics consultancy, integrating its PULSE Analytics data platform. Later that year, MMIT merged with Evaluate, a provider of commercial intelligence and predictive analytics. In 2022, MMIT, along with Evaluate, Panalgo, and The Dedham Group, launched the parent company Norstella to unify their services across the drug development lifecycle. Norstella later merged with Citeline, forming one of the largest pharma intelligence solutions providers globally, with a valuation of $5 billion.

Keywords: market access, pharmaceutical data, drug coverage, payer insights, patient access, formulary data, medical benefit information, specialty drugs, life sciences, commercialization, real-world data, healthcare analytics, biopharma solutions, pipeline to patient, drug reimbursement, payer strategy, HEOR, managed markets, pharmacy benefit management, PBM, patient journey